Patent · US Active

Imidazo based heterocycles

US7709468B2 · kind B2 · utility

13Cited by
4References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 1, 2006
Grant dateMay 4, 2010
Priority date
Expiry dateOct 27, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to novel imidazopyrazine and imidazopyrimidine compounds of formula (I)wherein the variables are as defined herein. The compounds of formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.